IL1R1 and arthritic joint disease: Treatment of the mice with the anti-ST2 antibody before and during development of arthritis did not reduce disease severity in two independent experiments, while blocking of the type 1 IL-1R with an isotype-matched anti-IL-1R1 blocking antibody essentially abrogated disease (Figure 4A-D).